Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01025271 · ClinicalTrials.gov registry record · NA
Cerebrospinal Fluid Pharmacokinetics of Daptomycin
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01025271 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 2 participants.
The verdict
NCT01025271, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a prospective pharmacokinetic study in patients having external ventricular drains with suspected external ventricular drain related bacterial meningitis. A single dose of daptomycin will be administered for the purposes of the study and PK samples will be obtained around this dosing.
Interventions
- DRUG Daptomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01025271
The ClinicalTrials.gov registry entry for NCT01025271 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Daptomycin is the first listed.
NCT01025271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01025271 about?
NCT01025271 is a clinical study titled "Cerebrospinal Fluid Pharmacokinetics of Daptomycin". This is a prospective pharmacokinetic study in patients having external ventricular drains with suspected external ventricular drain related bacterial meningitis. A single dose of daptomycin will be administered for the purposes of the study and PK samples will be obtained around this dosing.
What is the current status of trial NCT01025271?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01025271?
The interventions under investigation include: Daptomycin (DRUG).
Who is sponsoring clinical trial NCT01025271?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.